FII Holdings

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE290.209.85 (+3.51 %)
PREV CLOSE ( ) 280.35
OPEN PRICE ( ) 284.00
BID PRICE (QTY) 290.15 (881)
OFFER PRICE (QTY) 290.30 (100)
VOLUME 1515932
TODAY'S LOW / HIGH ( )281.50 294.90
52 WK LOW / HIGH ( )217.5 307
NSE290.4010.25 (+3.66 %)
PREV CLOSE( ) 280.15
OPEN PRICE ( ) 284.10
BID PRICE (QTY) 290.20 (2043)
OFFER PRICE (QTY) 290.40 (2463)
VOLUME 23710452
TODAY'S LOW / HIGH( ) 281.40 295.00
52 WK LOW / HIGH ( )217.5 307.1
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202403 % of Share Quarter Ended 202312 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.